Surgeons and Comprehensive Biomarker Testing for Lung Cancer Patients

Event dates

Webinar

Surgeons and Comprehensive Biomarker Testing for Lung Cancer Patients

What is the surgeon’s role in biomarker testing for lung cancer patients? In the November 4 episode of the STS Webinar Series, surgeons from different practice environments in the US and Canada offer perspectives about comprehensive biomarker testing, including for patients with inoperable or stage IV non-small cell lung cancer (NSCLC). They also explain how to implement a biomarker testing protocol and discuss targeted therapies for patients with resected epidermal growth factor receptor (EGFR)-positive adenocarcinoma.

This webinar is supported by AstraZeneca.


Moderators
Farhood Farjah, MD, MPH
University of Washington
Seattle, WA
M. Blair Marshall, MD
Brigham and Women’s Hospital
Boston, MA

 

Panelists
Jessica S. Donington, MD, MSCR
University of Chicago
Chicago, IL
Janet P. Edwards, MD, MPH
University of Calgary
Calgary, AB
Biniam Kidane, MD, MSc 
University of Manitoba
Winnipeg, MB
Svetlana Kotova, MD
Oregon Health & Science University
Portland, OR
Linda W. Martin, MD, MPH 
University of Virginia
Charlottesville, VA